{"id":18160,"date":"2020-11-04T14:27:10","date_gmt":"2020-11-04T13:27:10","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=18160"},"modified":"2022-06-06T14:28:25","modified_gmt":"2022-06-06T12:28:25","slug":"resultados-del-analisis-coste-consecuencia-de-la-extension-del-tratamiento-de-induccion-con-anti-vegf-en-emd","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/resultados-del-analisis-coste-consecuencia-de-la-extension-del-tratamiento-de-induccion-con-anti-vegf-en-emd\/","title":{"rendered":"Resultados del an\u00e1lisis coste-consecuencia de la extensi\u00f3n del tratamiento de inducci\u00f3n con anti-VEGF en EMD"},"content":{"rendered":"<p>Los resultados del an\u00e1lisis coste-consecuencia del aumento de la inducci\u00f3n de anti-VEGF (aflibercept, ranibizumab o bevacizumab) en el tratamiento de pacientes con edema macular diab\u00e9tico, indican que la extensi\u00f3n de 3 meses hasta 6 meses, supondr\u00eda un promedio de 14 inyecciones adicionales con un coste de 7.927\u20ac por paciente respondedor adicional. Estos son los datos recogidos en el art\u00edculo \u201cCost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients\u201d, publicado en BMC Ophthalmology, de los autores Ruiz-Moreno JM, de Andr\u00e9s-Nogales F, Oyag\u00fcez I.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Los resultados del an\u00e1lisis coste-consecuencia del aumento de la inducci\u00f3n de anti-VEGF (aflibercept, ranibizumab o bevacizumab) en el tratamiento de pacientes con edema macular diab\u00e9tico, indican que la extensi\u00f3n de 3 meses hasta 6 meses, supondr\u00eda un promedio de 14 inyecciones adicionales con un coste de 7.927\u20ac por paciente respondedor adicional. Estos son los datos&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/porib.com\/en\/resultados-del-analisis-coste-consecuencia-de-la-extension-del-tratamiento-de-induccion-con-anti-vegf-en-emd\/\" class=\"excerpt-read-more\">Read More<i class=\"fa fa-caret-right icon-caret-right\"><\/i><\/a><\/p>\n","protected":false},"author":4,"featured_media":18161,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-18160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultimas-noticias"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/18160"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=18160"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/18160\/revisions"}],"predecessor-version":[{"id":18162,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/18160\/revisions\/18162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media\/18161"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=18160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=18160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=18160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}